It's time to reveal the number 1️⃣ #DrugSafetyMatters episode of 2025! 🎧 Our listeners were keen to hear how versatile generative #AI models are raising the bar for what's possible in #pharmacovigilance, and what's needed to regulate their use. Niklas Norén tells us more 👉 ow.ly/iRPq50Xq0xP

🔝 As we enter 2026, it's time to reveal the most read #UppsalaReports article of 2025! Coming in at number 1️⃣, our 𝘋𝘌𝘌𝘗 𝘋𝘐𝘝𝘌 on medication errors outlines the critical stages where they can occur, those most at risk, and how we can find effective ways to prevent them. Read more 👉 ow.ly/F4q150W5qYF

Coming in at number 2️⃣ on our #DrugSafetyMatters countdown for 2025 is Episode 36. Levente Pápai, Lovisa Sandberg, and Sara Vidlin discuss the complexities and challenges of pregnancy-related #pharmacovigilance and the VigiBase pregnancy algorithm. Listen now 🎧 ow.ly/bT8250VrmAK

Our countdown of the top 5 #UppsalaReports articles continues 🔄 The number 2️⃣ spot belongs to an article from 2024 that was popular into 2025. Niklas Norén details how the role of #AI in PV is evolving and requires critically assessment to navigate the risks:

How can we help address the lack of medicine and vaccine safety data for pregnant people? Sara Vidlin, Levente Pápai, & Lovisa Sandberg tell us more about the VigiBase pregnancy algorithm in this #UppsalaReports article, which takes spot 3️⃣ on our countdown of the top 5 articles for 2025:

Shifting perspectives on patient engagement present new opportunities for the future of #pharmacovigilance. The number 3️⃣ pod on our 2025 countdown is a recording of the concluding fireside chat at #ISoPUppsala2025. 🎧 Listen now 👉 https://ow.ly/lRhN50WgWhy

Our countdown of the top 5 #UppsalaReports articles of 2025 continues 🔄 The article in the number 4 spot gave us a sneak peek at the content of the ISoP Annual Meeting and how the past can influence the future of #pharmacovigilance. More at the link below👇

🔄 We continue our countdown of the #DrugSafetyMatters top 5 episodes of 2025. In the ️4th spot, Henry Zakumumpa discusses data quality in ADR reports and what regulators and #pharmacovigilance centres can do to improve it. Tune in 🎧 https://ow.ly/PPiY50W6S6b

As 2025 comes to a close, we're counting down the top 5 #DrugSafetyMatters episodes of the past year. At number 5️⃣, we explore veterinary #pharmacovigilance with James Mount. 🎧 Listen to the episode for more 👉 ow.ly/9GlB50UVHqC

We may be nearing the end of 2025, but we're just starting our countdown of the 🔝top 5 #UppsalaReports articles of the past year. In the number 5️⃣ spot, we explore how #pharmacogenomics and #pharmacovigilance data can help address drug-induced problems:

🇳🇦 Namibia's partnership with local radio stations brings #MedSafetyWeek and pharmacovigilance to the nation's ears by featuring pharmacists and healthcare professionals as guest speakers. Read the latest print issue of #UppsalaReports to learn more 👉 https://ow.ly/fPnt50XJsih

Thank you to all our followers for your avid support throughout 2025 and for helping us spread #pharmacovigilance awareness far and wide. Wishing you and those you hold dear a festive and cheerful holiday season. From all of us, to all of you – #HappyHolidays ☃️

Throughout 2025, UMC staff presented their research posters at international conferences, covering various topics in #pharmacovigilance. View the posters online and discover other scientific articles from this year in our research library 👉 https://ow.ly/PUmL50XN5n5

What are the 4️⃣ pillars of the WHO Global Smart #Pharmacovigilance Strategy, and how will it help foster strong, adaptive, and trusted regulatory systems globally? Shanthi Pal unpacks the strategy in the latest episode of #DrugSafetyMatters. 🎧 Tune in 👉 ow.ly/Yrug50XLpiE #Pharmacovigilance#DrugSafetyMatters#PatientSafety #MedSky

A new article published in @bmc.springernature.com Infectious Diseases explores the factors contributing to incomplete reports of adverse drug reactions in Uganda🇺🇬 with a focus on HIV care, specifically dolutegravir-based treatment. Read the #OpenAccess article at the link below👇

Regional #pharmacovigilance centres have the power to unite trusted healthcare professionals. They've played a key role in the success of Iraq's #MedSafetyWeek campaigns, rallying hundreds of trained officers with access to local communities. Read more in #UppsalaReports: https://ow.ly/fPnt50XJsih

📚 New CIOMS publication: Artificial Intelligence in #Pharmacovigilance The #CIOMS Working Group XIV report on #AI in PV proposes a framework of principles and best practices for integrating and implementing AI systems into PV activities. Access it at the link below👇

Pharmacovigilance is not only a system; it is also a culture. This message rang true during #MedSafetyWeek activities in Aligarh, India🇮🇳, as healthcare workers and students came together to showcase that we all have the power to make medicines safer. Read More in #UppsalaReports👇

UMC researchers explore community perspectives on access to open-source methods in #pharmacovigilance, including interest in UMC methods and programming languages. Learn about the results of their survey in this research poster 👉 https://ow.ly/8Jkc50XB7V3#pharmacovigilance#R #Python #OpenSource

🇱🇺 Luxembourg has partnered with community and hospital pharmacists as #MedSafetyWeek ambassadors to raise awareness of ADR reporting and build a sustainable medicines safety culture. Learn how in the latest print issue of #UppsalaReports 👉 https://ow.ly/wm6850XBInr

It was non-stop action during the CHaSE career fair in Stockholm🇸🇪 as students and professionals stopped by our booth to learn more about UMC. We had a fantastic time engaging with everyone and sharing how they can apply their skills in the life sciences and medicine in the pursuit of patient safety.

Can #psychedelic trip reports aid #pharmacovigilance systems in detecting safety concerns? This #UppsalaReports article details how #AI analysis of user narratives from online forums like Erowid could help PV systems detect risks missed by traditional reporting👇

We continue our discussion on the use of #AI in #pharmacovigilance on the #DrugSafetyMatters podcast. Niklas Norén tells us how to keep pace with rapid technological developments while ensuring that sensitive patient data remains protected. 🎧 Tune in 👉 ow.ly/tibY50XAuCc

Substandard and falsified (SF) medicines threaten millions of people worldwide. Learn how investment in education, adoption of innovative technologies, and strengthening of pharmacovigilance systems can help address #FakeMeds / #FightTheFakes in #UppsalaReports👇

#MedSafetyWeek may be over, but we are still amazed by the participants' initiatives this year. From hospital outreach to TV spots, games, and more, there was no shortage of creative activities. Thanks to our 132 partners, planning team members, & YOU for making 2025 our biggest campaign to date! 🎉

A new report presents a set of recommendations, including streamlined data access, data harmonization, reproducible analytical workflows, & more, to enable the broader use of real-world evidence #RWE throughout #pharmacovigilance signal management. #OpenAccess at the link below👇

📖 Read how harnessing the power of students and university collaborations has expanded in-person activities and boosted engagement with Egypt🇪🇬's #MedSafetyWeek campaign in the latest print issue of #UppsalaReports. Dive inside 👉 https://ow.ly/X39L50XxsT3

Human and veterinary #pharmacovigilance share many cross-disciplinary approaches to improving human and animal health, despite focusing on different species. As #AMR Awareness Week ends, read the final article in our #OneHealth series to learn how we can enhance medicines safety👇

Antimicrobial resistance #AMR poses significant risks to global health. Learn how #pharmacovigilance can be integrated into the #OneHealth approach to monitor the use of antimicrobials and detect emerging resistance patterns in this #UppsalaReports article👇

Disproportionality analysis is the mainstay of many #pharmacovigilance organisations for detecting and assessing signals. However, its goal is often misunderstood and the approach misapplied. This #OpenAccess article charts the pitfalls and strategies to avoid or minimise them. Read more below👇

📣 It's World #AMR Awareness Week! Follow along as we join the global campaign to "Act Now: Protect Our Present, Secure Our Future." Visit the @who.int's website to learn more about #AntimicrobialResistance and access campaign materials 👉 ow.ly/TrJ550XtlaW

📚 What if medication safety were a school subject? As more young people turn to social media for health advice, introducing regular education on medication safety in schools could help address gaps in #HealthLiteracy and raise public awareness. Read more in #UppsalaReports👇

In this two-part episode of #DrugSafetyMatters, we're joined by Niklas Norén to discuss how #AI can add value to #pharmacovigilance and how a risk-based approach to its regulation can help maintain human oversight throughout the PV cycle. 🎧 Tune in to Part 1 to learn more 👉 ow.ly/iRPq50Xq0xP

#MedicationErrors are a leading cause of avoidable harm in healthcare, affecting millions of people worldwide each year. By understanding the different types of errors and finding effective ways to prevent them, we can improve the safety of medicines for everyone ✅ Learn more 👉 ow.ly/F4q150W5qYF

That's a wrap on this year's #MedSafetyWeek campaign! 🎉 Thanks for following our channels this week as we highlighted the importance of reporting side effects and how we all have the power to make medicines safer. Continue to report side effects and be a #MedSafetyHero💪

Making medicines safer requires global teamwork. From patients to healthcare professionals, regulators, and more – we all have a role to play 🤝 We are delighted to share a special video greeting with you from @drtedros.who.int of @who.int as we celebrate 10 years of the #MedSafetyWeek campaign 🎥

💊 Monitoring the safety of medicines doesn’t stop once they hit the pharmacy shelves. Whether you're a patient, healthcare professional, regulatory, or company, we all have the power to make medicines safer – #ReportSideEffects ✅ Learn more about the #MedSafetyWeek cause 👉 ow.ly/XEoc50LlhaJ

🩺 How can healthcare professionals help to make medicines safer? ️✔️ Inform patients of potential side effects ✔️ Show patients how to report them ✔️ Tell patients to read the patient information leaflet and follow dosage instructions ✔️ Report suspected side effects #MedSafetyWeek

We celebrate 10 years of #MedSafetyWeek with a special issue of #UppsalaReports 🎉 This issue covers the evolution of the campaign, features inspiring success stories from partner countries, and innovative approaches to address underreporting. Read it today 👉 https://ow.ly/lhHb50XmiRG

🦸 Here are 4 ways that patients and their carers can be #MedSafetyHeroes: ✔ Talk to HCPs about potential side effects ✔ Ask how to report side effects ✔ Read the patient information leaflet and follow dosage instructions ✔ Report suspected side effects #MedSafetyWeek

Do you know how to be a #MedSafetyHero? 💪 One of the key sources of information for suspected side effects to medicines is you, the patient. No matter how mild or how severe, don't wait – #ReportSideEffects and help make medicines safer. Read up on #MedSafetyWeek 👉 ow.ly/XEoc50LlhaJ

We all have the power to be a #MedSafetyHero 💪 Reporting side effects helps regulatory agencies understand more about the safety profile of medicines. Help keep others safe from future harm – #ReportSideEffects. 🔊 Join the #MedSafetyWeek cause 👉 ow.ly/XEoc50LlhaJ

📣 #MedSafetyWeek kicks off today! Medicines safety starts with you and me. Whether you're a patient, healthcare professional, regulator, or company, we all have the power to make medicines safer by reporting suspected side effects. Be a #MedSafetyHero – join the campaign 👉 http://ow.ly/XEoc50LlhaJ

Members of the WHO PIDM are reunited once more at the 43rd Partners' Meeting in Cairo. UMC was delighted to be in attendance and to engage with colleagues on-site on pertinent issues related to the theme and our #Vigiverse offering to PIDM members.

That's a wrap on #ISoP2025Cairo 🎉 Four days of courses, thought-provoking sessions, engaging discussions, and networking flew by at this year's ISoP Annual Meeting. Thanks to event organisers, sponsors, speakers, and attendees for making the conference a success!

📆 Join us next week for the 10th edition of #MedSafetyWeek! 118 countries 🌍 will come together to help spread the word about the importance of reporting suspected side effects from medicines. Help make medicines safer for all – join the campaign 👉 http://ow.ly/XEoc50LlhaJ

⏱️ The countdown is on to #ISoP2025Cairo! We will be on-site exhibiting, instructing, and presenting posters and sessions from 24–27 October in Cairo🇪🇬. Explore the UMC agenda in the thread below👇 and visit the conference website for all details 🌐 isop2025cairo.org

🎥 Since 2016, we've teamed up with pharmacovigilance stakeholders worldwide for #MedSafetyWeek. As we mark 10 years of the campaign, we wanted to know: 𝙬𝙝𝙖𝙩 𝙙𝙤𝙚𝙨 #𝙈𝙚𝙙𝙎𝙖𝙛𝙚𝙩𝙮𝙒𝙚𝙚𝙠 𝙢𝙚𝙖𝙣 𝙩𝙤 𝙩𝙝𝙚𝙢? The Philippines share their story in the film below👇

Hot off the press – we celebrate 10 years of #MedSafetyWeek with a special joint issue of #UppsalaReports 🎉 This issue covers the evolution of the campaign, features inspiring success stories from partner countries, and innovative approaches to address underreporting. 👉 https://ow.ly/E29k50XeSei

🌐 ISoP Latin American chapter pushes forward medicines safety innovation as over 200 participants gathered in Mérida🇲🇽 for the 7th Symposium. Read up on how #LATAM is dxriving innovation and collaboration in #pharmacovigilance in the #UppsalaReports article below👇